This brand name is authorized in Brazil
The drug DORILEN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Promethazine
UNII R61ZEH7I1I - PROMETHAZINE HYDROCHLORIDE
|
|
Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties. |
|
2
Dipyrone
UNII 6429L0L52Y - DIPYRONE
|
|
Metamizole sodium is a pyrazolone derivative with analgesic, antipyretic and slight antiinflammatory and spasmolytic properties. It has the most potent analgesic effect of all the pyrazolone derivatives. As with other analgesics, its mechanism of action has not been elucidated in detail. It includes inhibition of prostaglandin synthesis (PGE1 and PGE2) and reversible inhibition of platelet aggregation. It inhibits cyclo-oxygenase and influences the effect of arachidonic acid. |
|
3
Adiphenine
UNII 42B4PDY0AV - ADIPHENINE HYDROCHLORIDE
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 538816901111417, 538816902134410, 538816903130419 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
